MS-DArT-seq

MS-DArT-seq detects genome-wide DNA methylation patterns by leveraging methylation-sensitive DArT sequencing with MspI/HpaII digestion to infer methylation states across genomic features.

Key Features:

• Methyl Sensitive DArT Sequencing (MS-DArT-seq): Uses differential digestion by MspI/HpaII restriction enzymes to reveal methylation-dependent cleavage patterns across the genome.
• Computational Pipeline: A reproducible computational pipeline processes MS-DArT-seq data to identify methylated genomic sites.
• High Precision and Reliability: Demonstrates greater than 95% precision when benchmarked against Whole Genome Bisulfite Sequencing (WGBS).
• Broad Applicability: Applicable to species with or without a reference genome, enabling use across diverse organisms.
• Genomic Context and Specificity: Detects methylated sites in genic regions, transposons, and other genomic features; a pilot study analyzed 72,515 genomic sites and identified 5,846 methylated sites across 11 chromosomes, with many tissue-specific sites.
• Cost-Effectiveness: Provides comprehensive methylation profiling at reduced costs compared to traditional methods.

Scientific Applications:

• Epigenetic association studies: Enables genome-wide analysis of DNA methylation to investigate associations with phenotypes and diseases.
• Comparative and non-model organism studies: Facilitates methylation profiling in plant biology and other organisms lacking high-quality reference genomes.
• Developmental and tissue-specific regulation: Supports identification of tissue-specific methylation patterns to study developmental processes and gene regulation.

Methodology:

A reproducible computational pipeline for processing MS-DArT-seq data is used to identify methylated genomic sites and to compare MS-DArT-seq results with WGBS for precision assessment.